Autobahn Therapeutics
Latest round
- Series C
Last raised
- Jun 2024
Total raised
- $177M
Investors
- 16
About Autobahn Therapeutics
Founded in 2017, Autobahn Therapeutics, Inc. is dedicated to creating transformative therapies for CNS disorders.Autobahn Therapeutics specializes in the development of next-generation regenerative medicines focused on CNS disorders. Utilizing a brain-targeting chemistry platform, the company offers orally administered small molecule prodrugs designed for tailored central and peripheral distribution profiles.The company generates revenue through strategic partnerships and clinical collaborations that aid in the development and commercialization of innovative therapies. Revenue streams include milestone payments from clinical trial progress, royalty agreements on product sales, and potential licensing fees from successful drug approvals. Additionally, the company is exploring expansion into new geographic markets to enhance its reach and impact in CNS treatment.
Who invested in Autobahn Therapeutics
16 investors across 2 rounds
See all investors in Autobahn Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Autobahn Therapeutics
Who invested in Autobahn Therapeutics?
Autobahn Therapeutics has 16 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Autobahn Therapeutics raised?
Autobahn Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Autobahn Therapeutics last raise money?
Autobahn Therapeutics's most recent round on record is a Series C, in Jun 2024.
What does Autobahn Therapeutics do?
Founded in 2017, Autobahn Therapeutics, Inc.
Where is Autobahn Therapeutics headquartered?
Autobahn Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Autobahn Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Autobahn Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Autobahn Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.